Anhui Fengyuan Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 1,577.762 million compared to CNY 1,567.862 million a year ago. Operating income was CNY 76.243 million compared to CNY 79.905 million a year ago. Net income was CNY 57.751 million compared to CNY 56.566 million a year ago. Basic earnings per share from continuing operations was CNY 0.185 compared to CNY 0.1812 a year ago.